JP6416240B2 - 種々の皮膚症状の処置に有用なヒトｃ−ｘ−ｃケモカイン由来テトラペプチド - Google Patents

種々の皮膚症状の処置に有用なヒトｃ−ｘ−ｃケモカイン由来テトラペプチド Download PDF

Info

Publication number
JP6416240B2
JP6416240B2 JP2016519511A JP2016519511A JP6416240B2 JP 6416240 B2 JP6416240 B2 JP 6416240B2 JP 2016519511 A JP2016519511 A JP 2016519511A JP 2016519511 A JP2016519511 A JP 2016519511A JP 6416240 B2 JP6416240 B2 JP 6416240B2
Authority
JP
Japan
Prior art keywords
skin
seq
peptides
tetrapeptide
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016519511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016521746A5 (enExample
JP2016521746A (ja
Inventor
チャン，リジュアン
カーマイケル，ロビン
Original Assignee
ヘリックス バイオメディクス インコーポレイテッド
ヘリックス バイオメディクス インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヘリックス バイオメディクス インコーポレイテッド, ヘリックス バイオメディクス インコーポレイテッド filed Critical ヘリックス バイオメディクス インコーポレイテッド
Publication of JP2016521746A publication Critical patent/JP2016521746A/ja
Publication of JP2016521746A5 publication Critical patent/JP2016521746A5/ja
Application granted granted Critical
Publication of JP6416240B2 publication Critical patent/JP6416240B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
JP2016519511A 2013-06-14 2014-05-14 種々の皮膚症状の処置に有用なヒトｃ−ｘ−ｃケモカイン由来テトラペプチド Active JP6416240B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361835424P 2013-06-14 2013-06-14
US61/835,424 2013-06-14
PCT/US2014/037978 WO2014200651A1 (en) 2013-06-14 2014-05-14 Tetrapeptides derived from human c-x-c chemokines useful for treatment of various skin conditions

Publications (3)

Publication Number Publication Date
JP2016521746A JP2016521746A (ja) 2016-07-25
JP2016521746A5 JP2016521746A5 (enExample) 2017-04-27
JP6416240B2 true JP6416240B2 (ja) 2018-10-31

Family

ID=50943603

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016519511A Active JP6416240B2 (ja) 2013-06-14 2014-05-14 種々の皮膚症状の処置に有用なヒトｃ−ｘ−ｃケモカイン由来テトラペプチド

Country Status (21)

Country Link
US (1) US10195245B2 (enExample)
EP (1) EP3007716B1 (enExample)
JP (1) JP6416240B2 (enExample)
KR (1) KR102254260B1 (enExample)
CN (1) CN105324122B (enExample)
AR (1) AR096594A1 (enExample)
AU (1) AU2014278708B2 (enExample)
BR (1) BR112015031018B1 (enExample)
CA (1) CA2915174C (enExample)
CY (1) CY1119191T1 (enExample)
DK (1) DK3007716T3 (enExample)
ES (1) ES2631804T3 (enExample)
HU (1) HUE032970T2 (enExample)
MX (1) MX362846B (enExample)
MY (1) MY168981A (enExample)
PL (1) PL3007716T3 (enExample)
RU (1) RU2687151C2 (enExample)
SG (1) SG11201509048VA (enExample)
SI (1) SI3007716T1 (enExample)
TW (1) TWI511737B (enExample)
WO (1) WO2014200651A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110302088A (zh) * 2019-04-29 2019-10-08 杭州肽佳生物科技有限公司 一种包含修饰芋螺肽的化妆品组合物
AU2021211840B2 (en) * 2020-01-21 2024-08-29 Asc Regenity Ltd Cosmetic formulation for topical administration comprising novel peptides that improve appearance and regeneration of skin
PL245202B1 (pl) 2020-03-06 2024-06-03 Gdanski Univ Medyczny Lipopeptydowe koniugaty i ich sole, sposób wytwarzania lipopeptydowych koniugatów i ich soli, kompozycja farmaceutyczna zawierająca lipopeptydowy koniugat i jego sole do leczenia ran przewlekłych
WO2022098051A1 (ko) 2020-11-05 2022-05-12 한국생명공학연구원 항염 및 조직 재생작용을 갖는 신규 펩타이드
CN113698452B (zh) * 2021-08-23 2023-08-18 四川丽妍工坊生物科技有限公司 一种促皮肤修复肽、制备方法及其应用
EP4426715A1 (en) * 2021-11-02 2024-09-11 Enumita AS Tri-, tetra and pentapeptides, compositions thereof and their use in the therapy of psoriasis
US20240123022A1 (en) * 2021-12-16 2024-04-18 Ramakrishna Reddy ISANAKA A stable anti-angiogenic and anti-inflammatory pharmaceutical formulation and pharmaceutical combination for treatment and prevention of psoriasis
CN116407611A (zh) * 2021-12-29 2023-07-11 四川好医生攀西药业有限责任公司 一种多肽在制备预防或治疗皮肤损伤疾病产品上的应用
KR20230156265A (ko) 2022-05-03 2023-11-14 한국생명공학연구원 신규 펩타이드 및 이의 항염 및 재생 용도
KR20240086709A (ko) * 2022-11-18 2024-06-19 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT62312A (en) * 1990-03-05 1993-04-28 Cephalon Inc Process for producing chymotrypsin-like proteases and their inhibitors
FR2814076B1 (fr) * 2000-09-21 2002-12-20 Centre Nat Rech Scient Agent angiogenique et ses utilisations
WO2007026356A2 (en) 2005-08-29 2007-03-08 Healor Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
PL2027152T3 (pl) 2006-06-13 2012-04-30 Helix Biomedix Inc Fragmenty peptydów do indukowania syntezy białek macierzy zewnątrzkomórkowej
JP2007001981A (ja) * 2006-07-10 2007-01-11 Nippon Meat Packers Inc 皮膚組織の再生及び肌質改善効果のあるペプチドを含有する化粧品
EP2125878B1 (en) 2007-01-05 2013-02-20 Helix Biomedix, Inc. Short bio-active peptides for cellular and immunological modulation
PL2205623T3 (pl) 2007-10-29 2016-09-30 Ochronne tetrapeptydy do pielęgnacji skóry
EP2109054A1 (en) * 2008-04-09 2009-10-14 Biotempt B.V. Methods for identifying biologically active peptides and predicting their function
TWI429451B (zh) * 2011-10-26 2014-03-11 Nat Univ Tsing Hua 對具有ｅｌｒ－ｃｘｃ趨化素高度親和力的受體蛋白細胞所引發疾病之拮抗治療劑

Also Published As

Publication number Publication date
AU2014278708A1 (en) 2015-12-24
BR112015031018A2 (pt) 2018-09-25
KR20160018595A (ko) 2016-02-17
US20160184384A1 (en) 2016-06-30
ES2631804T3 (es) 2017-09-05
RU2687151C2 (ru) 2019-05-07
SI3007716T1 (sl) 2017-09-29
RU2015146679A (ru) 2017-07-17
CN105324122B (zh) 2019-08-27
TWI511737B (zh) 2015-12-11
KR102254260B1 (ko) 2021-05-20
US10195245B2 (en) 2019-02-05
MX2015017089A (es) 2016-04-11
RU2015146679A3 (enExample) 2018-03-21
MX362846B (es) 2019-02-19
AU2014278708B2 (en) 2017-12-07
CN105324122A (zh) 2016-02-10
HK1217436A1 (en) 2017-01-13
AR096594A1 (es) 2016-01-20
CA2915174C (en) 2019-10-29
EP3007716B1 (en) 2017-04-26
DK3007716T3 (en) 2017-07-31
CY1119191T1 (el) 2018-02-14
JP2016521746A (ja) 2016-07-25
HUE032970T2 (en) 2017-11-28
WO2014200651A1 (en) 2014-12-18
SG11201509048VA (en) 2015-12-30
TW201503896A (zh) 2015-02-01
MY168981A (en) 2019-01-29
CA2915174A1 (en) 2014-12-18
PL3007716T3 (pl) 2017-09-29
EP3007716A1 (en) 2016-04-20
BR112015031018B1 (pt) 2023-03-07
US20170007662A2 (en) 2017-01-12

Similar Documents

Publication Publication Date Title
KR102254260B1 (ko) 다양한 피부 병태의 치료에 유용한 인간 c-x-c 케모카인으로부터 유래된 테트라펩타이드
JP6348126B2 (ja) 創傷治癒を促進する生物活性短鎖ペプチド
CN101679495A (zh) 用于细胞学和免疫学调节的短的生物活性肽
ZHANG et al. GCC PATENT APPLICATION
HK1217436B (en) Tetrapeptides derived from human c-x-c chemokines useful for treatment of various skin conditions
Wang et al. Bioactive peptide HX-12C enhances fibroblast function through TGF-β/Smad signaling pathway and promotes wound healing in vitro and in vivo
HK1212243B (en) Short bio-active peptides for promoting wound healing

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170327

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170327

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180521

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180911

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181003

R150 Certificate of patent or registration of utility model

Ref document number: 6416240

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250